ac133
mAbexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
2
Phase 4
0
Earliest trial started Jan 1, 2008 (NCT01167751)
Timeline
Indications
Studied for
Mechanism of action
- Prominin-1INHIBITOR
PROM1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ac133
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01187654 | Phase 2/Phase 3 (Phase 3) | May 1, 2009 | Royan Institute |
| NCT01167751 | Phase 3 | Jan 1, 2008 | Baqiyatallah Medical Sciences University, Royan Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Royan Institute | Academic/Hospital | 2 | 2 | 1 | 2008 |
| Baqiyatallah Medical Sciences University | Academic/Hospital | 1 | 0 | 1 | 2008 |
2 organizations
Page 1 / 1